Clinical studies report low HDL and ApoA-I levels increase type 2 diabetes risk [4, 5], and infusion of HDL into people with type 2 diabetes has been found to decrease plasma glucose while simultaneously increasing plasma insulin [6]. The gene discussed is APOA1; the disease is type 2 diabetes mellitus.